Retracted: Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab
- PMID: 37547638
- PMCID: PMC10397468
- DOI: 10.1155/2023/9781974
Retracted: Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab
Abstract
[This retracts the article DOI: 10.1155/2022/4853481.].
Copyright © 2023 Contrast Media & Molecular Imaging.
Retraction of
-
Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab.Contrast Media Mol Imaging. 2022 Sep 5;2022:4853481. doi: 10.1155/2022/4853481. eCollection 2022. Contrast Media Mol Imaging. 2022. Retraction in: Contrast Media Mol Imaging. 2023 Jul 26;2023:9781974. doi: 10.1155/2023/9781974. PMID: 36118947 Free PMC article. Retracted.
References
Publication types
LinkOut - more resources
Full Text Sources